SILO MEXC RealStocks
Own real SILO shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:04:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Silo Pharma, Inc. (SILO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.93, with a market capitalization of $3.68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.10 to $10.43. This page covers its latest market performance, valuation, price trends and company information.
$3.68M | |
$1.77 | |
$1.93 | |
$1.61 | |
$1.71 | |
49.09K | |
65.37K | |
-- | |
$10.43 | |
$1.10 | |
-- | |
2026-06-30 |
Silo Pharma, Inc. (SILO) last closed at $1.93 as of 2026-11-19 01:00:00, up 8.19% ($0.14) from the previous close of $1.71.
During the latest regular trading session, SILO traded between $1.61 and $1.93, with a volume of 49.09K shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, Silo Pharma, Inc. (SILO) moved from $1.63 to $1.93, representing a gain of 18.59% ($0.30).
The stock traded between $1.39 and $1.98 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 97.15 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 8.9%
SILO is currently trading at $1.93, placing it 8.9% of the way from its 52-week low of $1.10 to its 52-week high of $10.43. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 3 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Silo Pharma, Inc. (SILO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SILO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SILO shares and USD.
SILO Shares to USD
1.00 SILO shares = 1.933 USD
Calculations are estimates based on the latest available price and are for reference only.